Clinical Trials Directory

Trials / Conditions / Nonneoplastic Condition

Nonneoplastic Condition

18 registered clinical trials studyying Nonneoplastic Condition.

StatusTrialSponsorPhase
CompletedBiomarkers in Blood and Tissue Samples From Patients With Epstein-Barr Virus-Positive Hodgkin Lymphoma
NCT01490801
Children's Oncology Group—
CompletedVaccine Therapy in Preventing Human Papillomavirus Infection in Young HIV-Positive Male Patients Who Have Sex
NCT01209325
AIDS Malignancy ConsortiumPhase 2
TerminatedBiomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Underg
NCT01319526
AIDS Malignancy Consortium—
CompletedInfrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neopl
NCT01164722
AIDS Malignancy ConsortiumPhase 3
UnknownT-Lymphocyte Infusion or Standard Therapy in Treating Patients at Risk of Cytomegalovirus Infection After a Do
NCT00986557
University Hospital BirminghamPhase 2
CompletedVaccine Therapy in Preventing HPV in HIV-Positive Women in India
NCT00667563
AIDS Malignancy ConsortiumPhase 1
CompletedStudy of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphom
NCT00981097
AIDS Malignancy Consortium—
CompletedHuman Papilloma Virus Infection in HIV-Positive Indian Men Who Have Sex With Men
NCT00919997
AIDS Malignancy Consortium—
CompletedS0816 Fludeoxyglucose F 18-PET/CT Imaging and Combination Chemotherapy With or Without Additional Chemotherapy
NCT00822120
SWOG Cancer Research NetworkPhase 2
CompletedComparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in M
NCT00955591
Jonsson Comprehensive Cancer CenterN/A
CompletedPrednisone or Dexamethasone in Newly Diagnosed, Previously Untreated Primary Immune Thrombocytopenic Purpura
NCT00657410
Gruppo Italiano Malattie EMatologiche dell'AdultoPhase 3
CompletedRituximab and Prednisone as First-Line Therapy in Treating Patients With Immune Thrombocytopenic Purpura
NCT00486421
Mayo ClinicEARLY_Phase 1
CompletedVaccine Therapy in Preventing Cytomegalovirus in Healthy Participants
NCT00722839
City of Hope Medical CenterPhase 1
CompletedVaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV
NCT00381875
National Institutes of Health Clinical Center (CC)Phase 1
Completed17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
NCT00132015
National Institutes of Health Clinical Center (CC)Phase 2
UnknownCombination Chemotherapy Followed By Donor Stem Cell Transplant in Treating Patients With Hemophagocytic Lymph
NCT00334672
Children's Cancer and Leukaemia GroupPhase 3
CompletedVaccine Therapy in Treating Patients With Epstein-Barr Virus-Related Cancer
NCT01147991
Cancer Research UKPhase 1
CompletedMeasuring Changes in Blood in Patients at High Risk of Cytomegalovirus Infection After Undergoing Donor Bone M
NCT00716911
City of Hope Medical CenterN/A